8,789
matching articles
10 Jan 2025 13:17 GMT
Eli Lilly and Alchemab Therapeutics partner to develop new ALS therapies
PMLiVE
10 Jan 2025 13:17 GMT
Bayer’s non-hormonal menopause drug shows promise in phase 3 breast cancer trial
PMLiVE
10 Jan 2025 13:17 GMT
Pfizer shares positive late-stage results for sasanlimab combination in bladder cancer
PMLiVE
9 Jan 2025 12:40 GMT
AstraZeneca’s Lynparza recommended by NICE to treat advanced breast cancer
PMLiVE
9 Jan 2025 12:28 GMT
FDA accepts updated protocol for Annovis’ phase 3 Alzheimer’s disease study
PMLiVE
9 Jan 2025 12:28 GMT
Sanofi and Alloy Therapeutics enter central nervous system deal worth over $427m
PMLiVE
8 Jan 2025 13:00 GMT
MHRA approves Italfarmaco’s Duvyzat to treat Duchenne muscular dystrophy
PMLiVE
8 Jan 2025 13:00 GMT
Axsome announces positive results from phase 3 Alzheimer’s disease programme
PMLiVE
